Copperwynd Financial, LLC Eli Lilly & CO Transaction History

Copperwynd Financial, LLC

$330 Million
Q3 2024

A detailed history of Copperwynd Financial, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Copperwynd Financial, LLC holds 4,019 shares of LLY stock, worth $3.2 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

4,019

Previous 3,979 1.01%

Holding current value

$3.2 Million

Previous $3.6 Million 1.17%

% of portfolio

1.08%

Previous 1.13%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$772.14 - $960.02 $30,885 - $38,400	40 Added 1.01%	4,019 $3.56 Million
Q2 2024 Aug 15, 2024	BUY	$724.87 - $909.04 $176,143 - $220,896	243 Added 6.5%	3,979 $3.6 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $239,841 - $320,873	405 Added 12.16%	3,736 $2.91 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $460,591 - $542,977	877 Added 35.74%	3,331 $1.94 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $819,409 - $1.13 Million	-1,885 Reduced 43.44%	2,454 $1.32 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $1.52 Million - $2.03 Million	4,339 New	4,339 $2.03 Million
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $2.28 Million - $2.68 Million	-8,181 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$234.69 - $291.66 $1.67 Million - $2.08 Million	7,121 Added 671.79%	8,181 $2.34 Million
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $238,341 - $295,782	1,060 New	1,060 $293,000
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $1.3 Million - $1.42 Million	-12,183 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $55,727 - $65,047	503 Added 4.31%	12,183 $1.35 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $1.3 Million - $1.53 Million	11,680 New	11,680 $1.52 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copperwynd Financial, LLC with notifications on news.

Account

Copperwynd Financial, LLC Eli Lilly & CO Transaction History